Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Genki Relaunches Health Insurance for Nomads
EIN Presswire
Genki Native now offers flexible worldwide health cover from one month up to lifelong COLOGNE, GERMANY, November 3, 2026 /EINPresswire.com/ -- Genki today announced a major update to its flagship international health insurance, Genki Native....
Peer-Reviewed Publication in Clinical & Experimental Allergy Reveals Potential Disease-Modifying Effect of Mabylon’s Allergen-Neutralizing Antibodies
GlobeNewswire, Inc.
Allergen-specific, human-derived IgG4 antibodies prevent allergic reactions by neutralizing allergens and redirecting them toward tolerance-associated immune pathways Mechanism-of-action observed across different allergy indications Study provides...
ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution
GlobeNewswire, Inc.
EINDHOVEN, the Netherlands, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord...
China’s Permanent Representative to the United Nations Office at Geneva and Other International Organizations in Switzerland Ambassador Jia Guide Publishes a Signed Article Titled “The People’s Republic of China and the United Nations: 55 Years Through…
Ministry of Foreign Affairs of the People's Republic of China
On October 27, 2026, H.E. Ambassador Jia Guide, Permanent Representative of the People’s Republic of China to the United Nations Office at Geneva and Other International Organizations in Switzerland, published a signed article titled “The People’s...
AELO Swiss Academy Highlights SkyAlps MPL Programme with Guaranteed First Officer Placement
GlobeNewswire, Inc.
GORDOLA, SWITZERLAND, Nov. 02, 2026 (GLOBE NEWSWIRE) -- GORDOLA, SWITZERLAND - November 02, 2026 - AELO Swiss Academy is drawing attention to the SkyAlps MPL Program with AELO Swiss Academy, an 18-month pilot training pathway that concludes with a...
Lantheus Announces Presentation of Data at the 2026 Clinical Trials on Alzheimer’s Disease Annual Meeting
GlobeNewswire, Inc.
BEDFORD, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient...
BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026
GlobeNewswire, Inc.
PALO ALTO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions,...
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026
GlobeNewswire, Inc.
Tokyo, Japan and Cambridge, UK, 30 October 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the third quarter ended 30 September 2026. The full report...
ICN condemns fatal attack on nurse in DRC and warns of deadly risks from health misinformation
EIN Presswire
GENèVE, GE, SWITZERLAND, October 29, 2026 /EINPresswire.com/ -- The International Council of Nurses (ICN) expresses its deepest condolences following the killing of a nurse and serious injury of another health worker while responding to an Ebola...
The Acute Hospital Care Market Is Projected to Grow at a Steady 6.6% CAGR Driven by Expanding Industry Applications
EIN Presswire
The Business Research Company’s The Acute Hospital Care Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, October 29, 2026 /EINPresswire.com/ -- The acute hospital care sector plays a...
Pharvaris to Present Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting
GlobeNewswire, Inc.
ZUG, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated...
Matternet Partners with Swisslog Healthcare's TransLogic to Bring Drone Delivery to Thousands of North American Hospitals
GlobeNewswire, Inc.
Swisslog Healthcare’s automated transport systems operate in more than 2,300 hospitals in North America, including 18 of the top 20 U.S. hospitals Network will deliver medication, laboratory specimens, and urgent supplies between hospital...
Swiss Brand 64K Cellssense Makes CIIE 2026 Debut with Focus on Asia
EIN Presswire
The Swiss-rooted longevity brand presents its exclusive delivery technology and anti-aging portfolio as it pursues professional partnerships across Asia GENEVA, GENEVA, SWITZERLAND, October 26, 2026 /EINPresswire.com/ -- 64K Cellssense, a...
Newron Pharmaceuticals to Participate in November Investor Conferences
GlobeNewswire, Inc.
MILAN and MORRISTOWN, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and...
Strong Cresemba® (isavuconazole) sales in Europe trigger USD 37.5 million milestone payment to Basilea
GlobeNewswire, Inc.
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 03, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets
GlobeNewswire, Inc.
Nxera has exercised its option to license lucerastat for Japan, South Korea, Taiwan and selected other Asia Pacific markets (excluding China), paying Idorsia CHF 7 million upfront and contributing to the global Phase 3 program.
Erbitux Market Report Explores Market Trends, Segment Analysis, and Business Strategies
EIN Presswire
The Business Research Company’s Erbitux Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON , UNITED KINGDOM, November 3, 2026 /EINPresswire.com/ -- The market for Erbitux has experienced...
ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026
GlobeNewswire, Inc.
EINDHOVEN, The Netherlands, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord...
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
GlobeNewswire, Inc.
2026 operating profit expected to reach CHF 115 million (previously CHF 70 million) driven by higher than expected Cresemba and Zevtera-related revenue of CHF 250 million (previously CHF 210 million) Cumulative cash flow target for “Agenda 2030”...
Save the Date: HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer
GlobeNewswire, Inc.
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 26, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces an expert webcast, co-hosted with Citigroup Global Markets Asia Limited...
Sign up for:
Switzerland Health Monitor
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.